BYSI News and Press, BeyondSpring Inc. From 08/26/21

Wanchunbulin, BeyondSpring’s 58%-owned subsidiary in China, to partner with Hengrui, the leader in oncology product R&D and commercialization in China, for the exclusive commercial and co-development rights for plinabulin in Greater China markets (“the Territory”...

In Q42021 (likely at SITC), AGEN is anticipated to publish updated 1181/Bal Phase 2 clinical data in MSS-CRC that shows 1181/Bal significantly outperforms current FDA approved 3rd line standard-of-care. The broader clinical/investment community may see much faster patient enrollment t...

Distinguished industry executive and entrepreneur recognized for the development of a first-in-class asset in the oncology space NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharma...

The biotech industry is a wild one indeed. It isn't uncommon to see shares of biotech companies double (or more) in just a day or two. That's what happened to BeyondSpring (NASDAQ: BYSI) on Aug. 4, when its stock skyrocketed by as much as 211% and ended the day's trading session up ...

Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome, a San Diego short-read company, for up to $800 million. Shanghai's Zai Lab and Schrödinger of New York formed a global collaboration to develop a novel oncology pr...

Gainers: SCWorx (NASDAQ:WORX) +28%, Aurinia Pharmaceuticals (NASDAQ:AUPH) +21%, BeyondSpring (NASDAQ:BYSI) +13%, Intersect ENT (NASDAQ:XENT) +12%, Caribou Biosciences (NASDAQ:CRBU) +11%. Losers: Dicerna Pharmaceuticals (NASDAQ:DRNA) -35%, iCAD (NAS...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “BeyondSpring Surged 191% Following Positive Topline Results from its DUBLIN-3 Registrational Trial” BeyondSpring (NASDAQ: BYSI) skyrocketed over 191% in premarket ...

COVID concerns claimed more victims on Wednesday. Hospitality and airline stocks lost ground during the session as worries about renewed pandemic restrictions weighed on those sectors. The retreat impacted stocks like Hyatt Hotels (NYSE:H), Marriott International (NASDAQ:MAR), Spirit Airlines...

4 Top Biotech Stocks To Know About This Week With COVID-19 resurging, health care stocks appear to be on investors‘ radars once again. For the most part, this part of the stock market today is home to many companies fighting the pandemic now. This would be the case whethe...

Shares of BeyondSpring (NASDAQ: BYSI) soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung cancer treatment. By the close of trading, BeyondSpring's stock price was up 176% after rising as much as 211% earlie...